Wednesday, September 30, 2020
6:00 PM – 8:00 PM CT
Please note this Virtual program is 7:00PM Eastern, 6:00PM Central, 5:00PM Mountain and 4:00PM Pacific.
- Interactive, case-based learning
- Infographic Treatment Challenge Cases
- Complimentary Personalized Online Poster Portal
Silvio Inzucchi, MD
Professor of Medicine
Yale University School of Medicine
New Haven, CT
Anne L. Peters, MD
Professor of Medicine (Clinical Scholar)
Keck School of Medicine
University of Southern California
Westside Center for Diabetes
Beverly Hills, CA
After completing the CME activity, learners should be better able to:
- Personalize the selection of therapies for the management of cardiovascular and renal risk in patients with T2DM based on up-to-date standards of care
- Determine the clinical implications of results from cardiovascular outcomes trials of SGLT2 inhibitors and GLP-1 receptor agonists
- Utilize guidelines-based strategies for treatment intensification in patients with T2DM not meeting their glycemic goals
This educational activity is intended for cardiologists, endocrinologists, primary care physicians, NPs, PAs, nurses, and other clinicians involved in the treatment of patients with T2DM.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in the care of patients with type 2 diabetes.
2.0 ANCC Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 2.0 contact hour(s) of continuing nursing education of RNs and APNs.
AAFP CREDIT INFORMATION
This Virtual Live activity, The CARES Approach: Improving Glycemic, Cardiovascular, and Renal Outcomes, from 10/01/2020 – 10/01/2021, has been reviewed and is acceptable for up to 1.75 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AOA Bureau of OMED is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The AOA Bureau of OMED, as a co-sponsor with Med Learning Group, designates this live program for a maximum of 2.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participant in this activity.
COMMISSION ON DIETETIC REGISTRATION
This program has received prior approval with the Commission on Dietetic Registration for Dietitians and RDs.
CONTINUING PHARMACY EDUCATION CREDIT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHARMACISTS AND PHARMACY TECHNICIANS
Amedco LLC designates this activity for a maximum of 2 knowledge-based CPE contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at firstname.lastname@example.org.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at email@example.com
Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.